CD4⁺CD25⁺CD127^low FoxP3⁺ regulatory T cells in Crohn’s disease

1. FLOYD DN, LANGHAM S, SÉVERAC HC, LEVESQUE BG. The economic and quality-of-life burden of Crohn’s disease in Europe and the United States, 2000 to 2013: a systematic review. Digestive diseases and sciences. 2015; 60(2):299-312.10.1007/s10620-014-3368-z25258034Search in Google Scholar

2. EBRAHIMPOUR S, SHAHBAZIM, KHALILI A, TAHOORI MT, ZAVARAN HOSSEINI A, AMARI A, et al. Elevated levels of IL-2 and IL-21 produced by CD4+ T cells in inflammatory bowel disease. J Biol Regul Homeost Agents. 2017; 31(2):279-87.Search in Google Scholar

3. HASANJANI RM, BAYANI M, SOLEIMANI AS, MOHAMMADNIA-AFROUZI M, NOURI H, EBRAHIMPOUR S. Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis. Journal of biological regulators and homeostatic agents. 2016; 30(3):675.Search in Google Scholar

4. GRANT CR, LIBERAL R, MIELI-VERGANI G, VERGANI D, LONGHI MS. Regulatory T-cells in autoimmune diseases: challenges, controversies and—yet—unanswered questions. Autoimmunity reviews. 2015; 14(2):105-16.10.1016/j.autrev.2014.10.01225449680Search in Google Scholar

5. MOHAMMADNIA-AFROUZI M, ZAVARAN HOSSEINI A, KHALILI A, ABEDIANKENARI S, HOSSEINI V, MALEKI I. Decrease of CD4+ CD25+ CD127low FoxP3+ regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients. Autoimmunity. 2015; 48(8):556-61.10.3109/08916934.2015.107083526333292Search in Google Scholar

6. MOHAMMADNIA-AFROUZI M, SHAHBAZI M, DAMAVANDI SB, GANJI GF, EBRAHIMPOUR S. Regulatory T-cell: Regulator of Host Defense in Infection. Journal of Molecular Biology Research. 2017; 7(1):9.10.5539/jmbr.v7n1p9Search in Google Scholar

7. BACCHETTA R, BARZAGHI F, RONCAROLO MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Annals of the New York Academy of Sciences. 2016.10.1111/nyas.1301126918796Search in Google Scholar

8. CAUDY AA, REDDY ST, CHATILA T, ATKINSON JP, VERBSKY JW. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like syndrome, and defective IL-10 expression from CD4 lymphocytes. Journal of Allergy and Clinical Immunology. 2007; 119(2):482-7.10.1016/j.jaci.2006.10.00717196245Search in Google Scholar

9. LI Y, WANG Y, LIU Y, WANG Y, ZUO X, LI Y, et al. The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease. Mediators of Inflammation. 2014; 2014:10.10.1155/2014/136329415158225214710Search in Google Scholar

10. LIU Z, FENG B-S, YANG S-B, CHEN X, SU J, YANG P-C. Interleukin (IL)-23 suppresses IL-10 in inflammatory bowel disease. Journal of Biological Chemistry. 2012; 287(5):3591-7.10.1074/jbc.M111.304949327101222158873Search in Google Scholar

11. HARVEY RF, BRADSHAW JM. A simple index of Crohn’s-disease activity. Lancet. 1980; 1(8167):514.Search in Google Scholar

12. KONTIAINEN S, SCHEININT, HALME L. Number of activated T-helper cells and NK cells in peripheral blood is decreased in severe Crohn’s disease. Apmis. 1996; 104(5):355-61.10.1111/j.1699-0463.1996.tb00727.x8703441Search in Google Scholar

13. DI SABATINO A, BIANCHERI P, PICONESE S, ROSADO MM, ARDIZZONE S, ROVEDATTI L, et al. Peripheral regulatory T cells and serum transforming growth factor-β: Relationship with clinical response to infliximab in Crohn’s disease. Inflammatory bowel diseases. 2010; 16(11):1891-7.10.1002/ibd.2127120848485Search in Google Scholar

14. MAUL J, LODDENKEMPER C, MUNDT P, BERG E, GIESE T, STALLMACH A, et al. Peripheraland intestinal regulatory CD4+ CD25 high T cells in inflammatory bowel disease. Gastroenterology. 2005; 128(7):1868-78.10.1053/j.gastro.2005.03.04315940622Search in Google Scholar

15. GUIDI L, FELICE C, PROCOLI A, BONANNO G, MARTINELLI E, MARZO M, et al. FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents. BioMed Research International. 2013; 2013:286368.10.1155/2013/286368376699424063002Search in Google Scholar

16. MAKITA S, KANAI T, OSHIMA S, URAUSHIHARA K, TOTSUKA T, SAWADA T, et al. CD4+ CD25bright T cells in human intestinal lamina propria as regulatory cells. The Journal of Immunology. 2004; 173(5):3119-30.10.4049/jimmunol.173.5.311915322172Search in Google Scholar

17. CUADRADO E, ALONSO M, DE JUAN MD, ECHANIZ P, ARENAS JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol. 2008; 14(10):15217.10.3748/wjg.14.1521269374518330941Search in Google Scholar

18. UENO A, JIJON H, CHAN R, FORD K, HIROTA C, KAPLAN GG, et al. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013; 19(12):2522-34.10.1097/MIB.0b013e3182a8570924097227Search in Google Scholar

19. SARUTA M, YU QT, FLESHNER PR, MANTEL PY, SCHMIDT-WEBER CB, BANHAM AH, et al. Characterization of FOXP3+CD4+ regulatory T cells in Crohn’s disease. Clin Immunol. 2007;125(3):281-90.10.1016/j.clim.2007.08.00317897887Search in Google Scholar

20. Sun M, He C, Cong Y, Liu Z. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal immunology. 2015; 8(5):969-78.10.1038/mi.2015.49454065426080708Search in Google Scholar

21. CHAUDHRY A, SAMSTEIN RM, TREUTING P, LIANG Y, PILSMC, HEINRICH J-M, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011; 34(4):566-78.10.1016/j.immuni.2011.03.018308848521511185Search in Google Scholar

22. COLLISON LW, CHATURVEDI V, HENDERSON AL, GIACOMIN PR, GUY C, BANKOTI J, et al. IL-35-mediated induction of a potent regulatory T cell population. Nature immunology. 2010; 11(12):1093-101.10.1038/ni.1952300839520953201Search in Google Scholar

23. FRANKE A, BALSCHUN T, KARLSEN TH, SVENTORAITYTE J, NIKOLAUS S, MAYR G, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40(11):1319-23.10.1038/ng.22118836448Search in Google Scholar

24. IYER SS, CHENG G. Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease. Critical reviews in immunology. 2012; 32(1):23-63.10.1615/CritRevImmunol.v32.i1.30Search in Google Scholar

25. MOHAMMADNIA-AFROUZI M, HOSSEINI AZ, KHALILI A, ABEDIANKENARI S, AMARI A, AGHILI B, et al. Altered microRNA expression and immunosuppressive cytokine production by regulatory T cells of ulcerative colitis patients. Immunological investigations. 2016; 45(1):63-74.10.3109/08820139.2015.110374926730791Search in Google Scholar